INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Pooled results from many studies on one question.

40 studies · page 1 of 2

2020 / Systematic review and dose-response meta-analysis

Circulating trimethylamine N-oxide concentrations are positively linked to higher hypertension prevalence.

A meta-analysis analyzed 8 studies comprising 11,750 individuals and 6,176 hypertensive cases. High circulating TMAO levels were associated with greater hypertension prevalence compared to low levels (RR: 1.12; 95% CI: 1.06, 1.17; P < 0.0001). In dose-response models, the relative risk of hypertension rose by 9% for each 5-μmol/L rise (RR: 1.09; 95% CI: 1.05, 1.14) and 20% for each 10-μmol/L rise in blood TMAO (RR: 1.20; 95% CI: 1.11, 1.30).

Ge X, Zheng L, Zhuang R, et al. Adv Nutr, 2020. PMID 31269204

2020 / Meta-analysis of randomized controlled trials

Vitamin C supplementation reduced blood pressure in adults with essential hypertension.

A meta-analysis of eight randomized controlled trials comprising 614 participants examined the effects of vitamin C on essential hypertension. Vitamin C supplementation lowered systolic blood pressure (WMD = -4.09; 95% CI: -5.56, -2.62) and diastolic blood pressure (WMD = -2.30; 95% CI: -4.27, -0.331). In trials providing at least 500 mg daily, systolic blood pressure was also significantly decreased (WMD = -5.01; 95% CI: -8.55, -1.48).

Guan Y, Dai P, Wang H Medicine (Baltimore), 2020. PMID 32080138

2020 / Systematic review and meta-analysis of randomized controlled trials

Salt substitutes lower systolic and diastolic blood pressure in stage 2 hypertension.

A meta-analysis of 10 studies with 11 randomized controlled trials and 1,119 participants assessed salt substitutes in stage 2 hypertension. Salt substitutes reduced systolic blood pressure by a weighted mean difference of -8.87 mmHg (95% CI: -11.19 to -6.55) and diastolic blood pressure by -4.04 mmHg (95% CI: -5.70 to -2.39). Diastolic reductions were observed in adults under 65 years but not in participants aged 65 and older.

Jafarnejad S, Mirzaei H, Clark CCT, et al. BMC Cardiovasc Disord, 2020. PMID 32106813

2020 / Cohort study and meta-analysis of prospective cohort studies

Pooled prospective studies found no significant association between potato consumption and total, cardiovascular, or stroke mortality.

In an NHANES cohort of 24,856 participants (mean follow-up 6.4 years, 3,433 deaths), higher potato consumption was initially associated with higher risks of total (42%), CVD (65%), cerebrovascular (26%), and cancer (52%) mortality (p < 0.001), but these associations disappeared after adjustment for confounding factors. In a pooled meta-analysis of prospective studies (98,569 participants), potato intake showed no significant association with total (RR = 1.25, 95% CI 0.98-1.60), CVD (RR = 0.99, 95% CI 0.90-1.08), or stroke mortality (RR = 0.94, 95% CI 0.85-1.03). However, individuals with higher potato intake displayed less favorable cardiometabolic profiles, including higher waist circumference (97.2 vs. 99.5 cm) and worse blood pressure, triglycerides, HDL-C, and TG/HDL-C ratio (all p < 0.001).

Shows an association, not proof of cause and effect.

Mazidi M, Katsiki N, Mikhailidis DP, et al. Arch Med Sci, 2020. PMID 32190135

2019 / Systematic review and meta-analysis of observational studies

French fries intake was linked to higher risk of diabetes and hypertension.

Researchers analyzed 28 reports examining potato intake and chronic disease risks. Total potato consumption showed no associations with all-cause mortality (RR 0.88, 95% CI 0.69-1.12), coronary heart disease, stroke, or colorectal cancer per 150 g/day increase. Conversely, each 150 g/day increase in French fries intake was linked to higher risks of type 2 diabetes (RR 1.66, 95% CI 1.43-1.94) and hypertension (RR 1.37, 95% CI 1.15-1.63), based on mostly low- to moderate-certainty evidence.

Shows an association, not proof of cause and effect.

Schwingshackl L, Schwedhelm C, Hoffmann G, et al. Eur J Nutr, 2019. PMID 29987352

2019 / Systematic reviews and meta-analyses of prospective cohorts and trials

Higher intake of dietary fiber was linked to lower mortality and disease incidence, and reduced bodyweight and blood pressure in trials.

Researchers analyzed 185 prospective studies and 58 clinical trials examining carbohydrate quality markers. Observational data suggested a 15-30% decrease in all-cause and cardiovascular mortality, coronary heart disease, stroke, type 2 diabetes, and colorectal cancer when comparing highest versus lowest dietary fiber consumers. Clinical trials showed significantly lower bodyweight, systolic blood pressure, and total cholesterol with higher dietary fiber intakes. Similar findings were observed for whole grains, whereas evidence for low glycemic index or load showed smaller or no risk reductions.

Reynolds A, Mann J, Cummings J, et al. Lancet, 2019. PMID 30638909

2018 / Meta-analysis of randomized controlled trials

Chlorella supplementation reduces blood pressure, cholesterol, and fasting glucose in randomized trials

A meta-analysis of 19 randomized controlled trials with 797 subjects assessed Chlorella supplementation on cardiovascular risk markers. Chlorella significantly reduced total cholesterol by -9.09 mg/dL (95% CI -12.91 to -5.26), LDL cholesterol by -8.32 mg/dL (95% CI -12.22 to -4.42), systolic blood pressure by -4.51 mmHg (95% CI -6.53 to -2.48), diastolic blood pressure by -1.64 mmHg (95% CI -3.28 to -0.01), and fasting blood glucose by -4.23 mg/dL (95% CI -8.29 to -0.17). Triglycerides, HDL cholesterol, and BMI did not change significantly.

Fallah AA, Sarmast E, Habibian Dehkordi S, et al. Clin Nutr, 2018. PMID 29037431

2018 / Systematic review

Evidence for superfood effects on metabolic syndrome risk factors remains limited

A systematic review evaluated 113 controlled human intervention trials testing 17 putative superfoods on risk markers for metabolic syndrome. Studied foods included garlic (21 trials), flaxseed (22 trials), cocoa (16 trials), blueberries (8 trials), and strawberries (7 trials). The authors found limited overall evidence for beneficial impacts on waist circumference, BMI, blood pressure, blood glucose, or lipids, citing inconsistent findings across trials and a small number of studies for many evaluated foods.

van den Driessche JJ, Plat J, Mensink RP Food Funct, 2018. PMID 29557436

2018 / Systematic review and meta-analysis of controlled trials

The Portfolio dietary pattern significantly reduced LDL-C by ~17% and improved multiple cardiometabolic risk factors in hyperlipidemic participants.

A systematic review and meta-analysis of 7 controlled trial comparisons (439 participants with hyperlipidemia) evaluated the Portfolio dietary pattern on a background NCEP Step II diet versus an NCEP Step II diet alone. The Portfolio diet significantly reduced LDL-C by ~17% (MD, -0.73 mmol/L [95% CI, -0.89 to -0.56 mmol/L]) as well as non-HDL-C, apolipoprotein B, total cholesterol, triglycerides, systolic and diastolic blood pressure, C-reactive protein, and estimated 10-year CHD risk (all p < 0.05). No effect was seen on HDL-C or body weight. Certainty of evidence via GRADE was high for LDL-C and most lipid outcomes, and moderate for other outcomes.

Chiavaroli L, Nishi SK, Khan TA, et al. Prog Cardiovasc Dis, 2018. PMID 29807048

2018 / Meta-analysis of observational studies

A vegan diet was associated with a more favourable cardiometabolic profile compared to an omnivorous diet in most countries.

A meta-analysis of 40 observational studies assessed cardiometabolic risk factors in 12,619 vegans and 179,630 omnivores. Compared to controls, vegans had lower body mass index (-1.72 kg/m2, CI -2.30 to -1.16), waist circumference (-2.35 cm, CI -3.93 to -0.76), LDL cholesterol (-0.49 mmol/L, CI -0.62 to -0.36), triglycerides (-0.14 mmol/L, CI -0.24 to -0.05), fasting blood glucose (-0.23 mmol/L, CI -0.35 to -0.10), systolic blood pressure (-2.56 mmHg, CI -4.66 to -0.45), and diastolic blood pressure (-1.33 mmHg, CI -2.67 to -0.02; p<0.0001 for all). In several large studies from Taiwan, however, a vegan diet was not associated with favourable cardio-metabolic risk factors compared to control diets.

Shows an association, not proof of cause and effect.

Benatar JR, Stewart RAH PLoS One, 2018. PMID 30571724

2017 / Meta-analysis of prospective cohort studies

Overweight and obesity are associated with increased risk of developing hypertension

A meta-analysis of 10 prospective cohort studies with 173,828 participants assessed the link between excess weight and hypertension. Compared to normal weight, risk ratios for hypertension were 1.52 (95% CI: 1.37, 1.67) for overweight and 2.17 (95% CI: 1.84, 2.50) for obesity. The excess risk attributable to overweight was 32% (95% CI: 24%, 40%) and to obesity was 47% (95% CI: 40%, 54%).

Shows an association, not proof of cause and effect.

Poorolajal J, Hooshmand E, Bahrami M, et al. J Public Health (Oxf), 2017. PMID 27521927

2017 / Systematic review and meta-analysis of cohort studies

White rice intake was associated with total chronic disease risk in women.

A systematic review identified 19 cohort studies on rice intake, chronic conditions, and mortality. In a meta-analysis of 12 cohorts, comparing extreme categories of rice intake showed a non-significant trend for total chronic diseases (RR 1.11, 95% CI: 0.96 to 1.29), with an association present in women (RR 1.40, 95% CI: 1.13 to 1.73) but not men (RR 0.95, 95% CI: 0.72 to 1.24). Across five cohorts, high intake was not associated with mortality overall (RR 0.97, 95% CI: 0.88 to 1.06), but linked to lower mortality in men (RR 0.87, 95% CI: 0.81 to 0.94).

Shows an association, not proof of cause and effect.

Saneei P, Larijani B, Esmaillzadeh A Public Health Nutr, 2017. PMID 27577106

2017 / Meta-analysis of randomized controlled trials

Blueberry supplementation did not significantly improve blood pressure in clinical trials

A meta-analysis of 6 randomized controlled trials with 204 participants examined blueberry supplementation. The intervention showed no significant effect on systolic blood pressure (mean difference -0.28 mmHg, 95% CI: -1.11 to 0.56) or diastolic blood pressure (mean difference -0.5 mmHg, 95% CI: -1.24 to 0.24). Overall, findings did not demonstrate clinical efficacy for improving blood pressure.

Zhu Y, Sun J, Lu W, et al. J Hum Hypertens, 2017. PMID 27654329

2017 / Meta-analysis of randomized controlled trials

Higher red meat intake did not affect cardiovascular risk factors in trial meta-analysis

A meta-analysis of 24 randomized controlled trials in adults aged 19 and older compared red meat intake of at least 0.5 versus under 0.5 servings daily. Red meat intake did not affect postintervention blood lipids, lipoproteins, or blood pressure (P > 0.05). Across all subjects, total cholesterol, LDL cholesterol, HDL cholesterol, triglycerides, and diastolic blood pressure decreased over time.

NANO counterpoint →

O'Connor LE, Kim JE, Campbell WW Am J Clin Nutr, 2017. PMID 27881394

2017 / Meta-analysis of randomized controlled trials

Oral potassium supplementation modestly reduced blood pressure in adults with primary hypertension

A meta-analysis evaluated 23 randomized placebo-controlled trials encompassing 1,213 individuals with primary hypertension treated for at least 4 weeks. Potassium supplementation reduced systolic blood pressure by 4.25 mmHg (95% CI: -5.96 to -2.53) and diastolic blood pressure by 2.53 mmHg (95% CI: -4.05 to -1.02). The authors reported no significant adverse events associated with the intervention.

Poorolajal J, Zeraati F, Soltanian AR, et al. PLoS One, 2017. PMID 28419159

2016 / Systematic review and meta-analysis of randomized controlled trials

Flaxseed supplements reduce systolic and diastolic blood pressure in randomized controlled trials

A meta-analysis of 15 randomized trials comprising 1,302 subjects found that flaxseed products significantly lowered systolic blood pressure (WMD: -2.85 mmHg, 95% CI: -5.37 to -0.33, p = 0.027) and diastolic blood pressure (WMD: -2.39 mmHg, 95% CI: -3.78 to -0.99, p = 0.001). Systolic drops were significant with powder but not oil or lignans, whereas diastolic declines occurred with both powder and oil forms.

Ursoniu S, Sahebkar A, Andrica F, et al. Clin Nutr, 2016. PMID 26071633

2016 / Updated meta-analysis and review of randomized controlled trials

Garlic preparations reduced systolic and diastolic blood pressure, with larger reductions seen in hypertensive individuals.

Researchers updated a meta-analysis of randomized controlled trials evaluating the effect of garlic preparations on blood pressure and reviewed its effects on cholesterol and immunity. In 20 trials with 970 participants, garlic decreased systolic blood pressure by a mean ± SE of 5.1 ± 2.2 mm Hg (P < 0.001) and diastolic blood pressure by 2.5 ± 1.6 mm Hg (P < 0.002) compared with placebo. In trials of hypertensive subjects, reductions were larger: 8.7 ± 2.2 mm Hg for SBP (P < 0.001; n = 10) and 6.1 ± 1.3 mm Hg for DBP (P < 0.001; n = 6). A previously published meta-analysis cited in the review noted a 10% reduction in total and LDL cholesterol when taken for >2 months by individuals with slightly elevated levels, and clinical trials showed reductions in upper respiratory infections.

Ried K J Nutr, 2016. PMID 26764326

2016 / Systematic review and meta-analysis of randomized controlled trials

Weight loss diets reduced blood pressure and body weight in adults with hypertension.

In a systematic review of eight randomized trials with 2,100 adults with primary hypertension, dietary weight loss interventions lasting 6 to 36 months lowered systolic blood pressure by -4.5 mm Hg (95% CI -7.2 to -1.8 mm Hg) and diastolic blood pressure by -3.2 mm Hg (95% CI -4.8 to -1.5 mm Hg). Participants on weight-reducing diets also lost weight compared to controls (mean difference -4.0 kg, 95% CI -4.8 to -3.2 kg). Effects on mortality and morbidity remain unknown.

Semlitsch T, Jeitler K, Berghold A, et al. Cochrane Database Syst Rev, 2016. PMID 26934541

2016 / Meta-analysis of prospective clinical studies

Acute energy drink consumption raised systolic and diastolic blood pressure in clinical studies.

A meta-analysis of 15 prospective clinical studies evaluated hemodynamic outcomes after acute energy drink intake. Systolic blood pressure increased significantly by 4.44 mm Hg (95% CI 2.71 to 6.17; n = 340) and diastolic pressure rose by 2.73 mm Hg (95% CI 1.52 to 3.95; n = 322). Heart rate changes were not statistically significant (0.80 beats per minute, 95% CI -1.26 to 2.87), while drinks delivering at least 200 mg caffeine raised systolic pressure by 6.44 mm Hg.

Shah SA, Chu BW, Lacey CS, et al. Ann Pharmacother, 2016. PMID 27340146

2016 / Systematic review and meta-analysis of randomized controlled trials

Nigella sativa supplementation reduced systolic and diastolic blood pressure in randomized trials.

A meta-analysis evaluated 11 randomized controlled trials investigating Nigella sativa in 860 normotensive or hypertensive adults over an average of 8.3 weeks. Compared to control groups, Nigella sativa significantly reduced systolic blood pressure by 3.26 mmHg (95% CI: -5.10, -1.42) and diastolic blood pressure by 2.80 mmHg (95% CI: -4.28, -1.32). Powder formulations showed a greater blood-pressure-lowering effect than oil preparations.

Sahebkar A, Soranna D, Liu X, et al. J Hypertens, 2016. PMID 27512971

2015 / Systematic review and meta-analysis of randomized controlled trials

Vitamin D supplementation did not lower blood pressure in randomized controlled trials

A meta-analysis of 46 randomized placebo-controlled trials with 4,541 participants found no effect of vitamin D supplementation on systolic blood pressure (effect size 0.0 mm Hg; 95% CI, -0.8 to 0.8) or diastolic blood pressure (effect size -0.1 mm Hg; 95% CI, -0.6 to 0.5). Individual patient data from 27 trials (3,092 participants) showed similar null effects. Subgroup analyses found no baseline factors predictive of response.

Beveridge LA, Struthers AD, Khan F, et al. JAMA Intern Med, 2015. PMID 25775274

2015 / Meta-analysis of randomized controlled trials

Garlic supplementation lowered systolic and diastolic blood pressure in hypertensive patients.

A meta-analysis evaluated 7 randomized placebo-controlled trials investigating garlic for blood pressure management in hypertensive patients. Compared to placebo, garlic significantly decreased systolic blood pressure (WMD: -6.71 mmHg; 95% CI: -12.44 to -0.99; P = 0.02) and diastolic blood pressure (WMD: -4.79 mmHg; 95% CI: -6.60 to -2.99; P < 0.00001). No serious adverse events were documented across the trials.

Xiong XJ, Wang PQ, Li SJ, et al. Phytomedicine, 2015. PMID 25837272

2015 / Prospective cohort studies and fixed-effects meta-analysis

Higher consumption of total meat and poultry was linked to an increased risk of developing hypertension in three prospective cohorts.

Researchers analyzed the association between long-term intake of animal flesh and incident hypertension across three prospective cohorts: NHS, NHS II, and HPFS, followed by a fixed-effects meta-analysis. Compared with intake of less than 1 serving/month, consumption of at least 1 serving/day was associated with pooled hazard ratios of 1.30 (95% CI 1.23-1.39) for total meat, 1.22 (95% CI 1.12-1.34) for poultry, and 1.05 (95% CI 0.98-1.13) for seafood. Consuming any animal flesh at least 1 serving/day was linked to higher risk [pooled HR = 1.30 (95% CI 1.16-1.47)]. Seafood consumption showed a weak but significant trend toward increased hypertension risk, being associated with risk in HPFS and NHS II, but not NHS.

Shows an association, not proof of cause and effect.

Borgi L, Curhan GC, Willett WC, et al. J Hypertens, 2015. PMID 26237562

2014 / Systematic review and meta-analysis of controlled feeding trials

Dietary pulses exchanged isocalorically for other foods significantly reduced systolic and mean arterial blood pressure in controlled feeding trials.

A systematic review and meta-analysis evaluated 8 isocaloric controlled feeding trials (n = 554 participants with and without hypertension) of at least 3 weeks duration to assess the effect of dietary pulses on blood pressure. When exchanged isocalorically for other foods, dietary pulses significantly lowered systolic blood pressure (MD = -2.25 mm Hg, 95% CI: -4.22 to -0.28, P = 0.03) and mean arterial blood pressure (MD = -0.75 mm Hg, 95% CI: -1.44 to -0.06, P = 0.03). Diastolic blood pressure was non-significantly lowered (MD = -0.71 mm Hg, 95% CI: -1.74 to 0.31, P = 0.17). Significant heterogeneity was observed for all outcomes.

Jayalath VH, de Souza RJ, Sievenpiper JL, et al. Am J Hypertens, 2014. PMID 24014659